Inari Medical Stock Filter Stocks by Fundamentals
| NARI Stock | USD 49.48 0.18 0.36% |
Inari Medical fundamentals help investors to digest information that contributes to Inari Medical's financial success or failures. It also enables traders to predict the movement of Inari Stock. The fundamental analysis module provides a way to measure Inari Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inari Medical stock.
Inari | Shares Owned by Institutions |
Inari Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Inari Medical from analyzing Inari Medical's financial statements. These drivers represent accounts that assess Inari Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inari Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.0B | 2.8B | 4.5B | 3.4B | 3.7B | 2.4B | |
| Enterprise Value | 2.0B | 2.7B | 4.5B | 3.3B | 3.7B | 2.4B |
Inari Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inari Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inari Medical's managers, analysts, and investors.Environmental | Governance | Social |
Inari Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Inari Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Inari Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Inari Medical's value.| Shares | Jpmorgan Chase & Co | 2024-06-30 | 1.2 M | Bamco Inc | 2024-09-30 | 1 M | American Century Companies Inc | 2024-09-30 | 979.4 K | Mackenzie Investments | 2024-09-30 | 853.8 K | Point72 Asset Management, L.p. | 2024-09-30 | 805.6 K | Manufacturers Life Insurance Co | 2024-09-30 | 795.1 K | Fuller & Thaler Asset Management Inc | 2024-09-30 | 768.5 K | Bank Of America Corp | 2024-06-30 | 667.2 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 658 K | Blackrock Inc | 2024-06-30 | 8.4 M | Vanguard Group Inc | 2024-09-30 | 5.6 M |
Inari Fundamentals
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0321 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 2.83 B | ||||
| Shares Outstanding | 58.54 M | ||||
| Shares Owned By Insiders | 8.65 % | ||||
| Shares Owned By Institutions | 95.52 % | ||||
| Number Of Shares Shorted | 3.69 M | ||||
| Price To Earning | 275.35 X | ||||
| Price To Book | 6.69 X | ||||
| Price To Sales | 5.04 X | ||||
| Revenue | 493.63 M | ||||
| Gross Profit | 338.96 M | ||||
| EBITDA | 7.11 M | ||||
| Net Income | (1.64 M) | ||||
| Cash And Equivalents | 330.5 M | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 32.05 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 10.04 X | ||||
| Book Value Per Share | 7.44 X | ||||
| Cash Flow From Operations | 35.93 M | ||||
| Short Ratio | 3.79 X | ||||
| Earnings Per Share | (1.35) X | ||||
| Price To Earnings To Growth | (1.88) X | ||||
| Target Price | 63.0 | ||||
| Number Of Employees | 1.3 K | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 2.9 B | ||||
| Total Asset | 674.24 M | ||||
| Retained Earnings | (48.49 M) | ||||
| Working Capital | 159.22 M | ||||
| Net Asset | 674.24 M |
About Inari Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:Check out Inari Medical Piotroski F Score and Inari Medical Altman Z Score analysis. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (1.35) | Revenue Per Share 9.901 | Quarterly Revenue Growth 0.214 | Return On Assets (0.03) |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.